Orforglipron: the new kid on the GLP-1 block
Lloyd Price
MAY 19, 2024
Eli Lilly licensed the worldwide development and commercialisation rights for Orforglipron from Chugai in 2018. Mergers, Acquisitions, Growth and Strategy for Healthcare Technology companies HealthTech M&A - Buy Side, Sell Side, Growth & Strategy services for companies in Europe, Middle East and Africa. Subscribe Today!
Let's personalize your content